This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bisichem Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Seeun Jeon
Introduction
Seeun Jeon is an accomplished inventor based in Seongnam, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. His work focuses on creating innovative solutions for treating cancers and infectious diseases.
Latest Patents
Seeun Jeon holds a patent for "Fused heteroaryl hydroxamates as STING agonists." This invention provides novel substituted heterocyclic compounds that can be utilized as agonists of the Stimulator of Interferon Genes (STING). The compounds are represented by specific formulas and can be used in various forms, including pharmaceutically acceptable salts and prodrugs. This innovation has the potential to advance treatment options for cancers and certain infectious diseases.
Career Highlights
Seeun Jeon is currently employed at Bisichem Co., Ltd., where he continues to develop groundbreaking pharmaceutical compounds. His expertise in medicinal chemistry and innovative thinking has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Seeun Jeon has collaborated with talented individuals such as Jinwoo Lee and Sunhwa Jeon. These partnerships have fostered a creative environment that encourages the development of new ideas and solutions.
Conclusion
Seeun Jeon's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire future developments in the treatment of serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile